AzTrials
AzTrials

Diabetes Mellitus, Type 1TeensConnectNCT01783327

Teens-Connect: Preventive Psycho-education for Transitioning Teens With Diabetes

A study testing Teens-Connect and Planet D in people with Diabetes Mellitus, Type 1, run by Yale University at 2 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to evaluate the use of a state-of the art internet psycho-educational program in clinical practice (Teens-Connect), compared to use of a standard and widely available internet diabetes program for youth (Planet D™) in a mixed-method randomized clinical trial design. Read more about this study

Who is it for?
Ages 11 to 14 years
Conditions the study is for
Diabetes Mellitus, Type 1
What is being tested?
Teens-Connect and Planet D
Could I receive a placebo?
No, everyone receives an active treatment
How many people
124 participants
Where
2 sitesUnited States
Study dates
Jul 2012to Aug 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 11 to 14 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Diagnosed with type 1 diabetes for at least 6 months
  • Age 11 to 14 years
  • English-speaking
  • Assent
  • Parent/guardian consent to participate in study

Who cannot join

  • Previous exposure to TEENCOPE and/or Managing Diabetes

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • Yale University School of Nursing

    New Haven, Connecticut, 06519

  • Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania, 19104

Other trials in United States

About this study

The purpose of this study is to evaluate the use of a state-of the art internet psycho-educational program in clinical practice (Teens-Connect), compared to use of a standard and widely available internet diabetes program for youth (Planet D™) in a mixed-method randomized clinical trial design.

Read the detailed description

The aims are:

  1. To evaluate the efficacy and cost-effectiveness of provider-prescribed Teens-Connect (TEENCOPE™+Managing Diabetes) in pediatric diabetes practice compared to prescription of Planet D™. The hypotheses to be studied are:
  2. Youth who participate in Teens-Connect will have better metabolic control (A1c) and quality of life (QOL) than those who participate in Planet D.
  3. These effects will be mediated by improvements in stress/coping, self-efficacy, diabetes problem-solving, and self-management.
  4. Teens-Connect prescribed by providers in diabetes clinics will be a cost-effective approach to reduce A1c and improve quality-adjusted life years (QALYs) for youth with T1D.
  5. To compare the reach, efficacy, adoption, implementation, and maintenance (RE-AIM) of the two provider-prescribed psycho-educational internet programs.
Being tested
Teens-Connect, Planet D
Keywords
Diabetes Mellitus, Type 1, Self care, Coping skills, Adolescent, Internet, Intervention Studies, Chronic Disease
Medical subject headings
Diabetes Mellitus, Type 1, Chronic Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Teens-ConnectBehavioural

    Teens-Connect combines Managing Diabetes and TEENCOPE. Managing Diabetes consists of 5 sessions on age-appropriate, educational content related to diabetes problem-solving and self-efficacy to improve self-management. TEENCOPE consists of 5 sessions designed to increase youth's sense of competence and mastery by retraining inappropriate or non-constructive coping styles and forming more positive styles and patterns of behavior. The program is highly interactive and youth can talk with each other on an online moderated discussion board. Youth will be asked to use the website at least twice per week for 4 weeks.

  • Planet DBehavioural

    Planet D provides age-appropriate diabetes education on a variety of topics and social networking discussion boards on diabetes, food and exercise, personal interests, and diabetes camp. Planet D addresses emotions and self-management through education and social networking. Youth who register can also create a profile, upload and share pictures, identify favorite news and blog feeds as well as provide comments or tags to other members. Planet D has been online since 2007 and contains numerous diabetes-related articles geared toward youth as well as a secure message board. Youth will be asked to interact with the website twice a week for 4 weeks.

Study groups in NCT01783327
Study groupRoleWhat they receive
Teens-ConnectExperimentalThe Teens-Connect Program is an internet-based program that combines Managing Diabetes and TEENCOPE.
Receives: Behavioral: Teens-Connect
Planet DActive comparatorPlanet D is an internet program developed by the American Diabetes Association for children and adolescents with diabetes.
Receives: Behavioral: Planet D

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from baseline hemoglobin A1c over 12 months

    Measured: Baseline, 6 weeks, 6 months, 12 months

  2. Change from baseline quality of life over 12 months

    Measured: Baseline, 6 weeks, 6 months, 12 months

Secondary outcomes (6)
  1. Change from baseline coping/Stress over 12 months

    Coping/stress will be measured using the Perceived Stress Scale

    Measured: Baseline, 6 weeks, 6 months, 12 months

  2. Change from baseline self-efficacy over 12 months

    Self-efficacy will be assessed using the Self-efficacy for Diabetes Scale

    Measured: Baseline, 6 weeks, 6 months, 12 months

  3. Change from baseline problem-solving over 12 months

    Problem-solving will be assessed using the Self-Management of Diabetes-Adolescent (SMOD-A) questionnaire

    Measured: Baseline, 6 weeks, 6 months, 12 months

  4. Change from baseline self-management over 12 months

    Self-management will be assessed using the Self-care Inventory (SCI)

    Measured: Baseline, 6 weeks, 6 months, 12 months

  5. Costs

    Costs will be assessed using financial and staff records

    Measured: 6 months

  6. Change from baseline quality adjusted life years over 12 months

    Quality adjusted life years will be assessed using the Health Utilities Index Step 3 (Adolescent and Parent)

    Measured: Baseline, 6 weeks, 6 months, 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Feb 2013 (estimated)
  2. Study startJul 2012
  3. Primary completionMay 2015
  4. Study completionAug 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Care provider, Investigator, Outcomes assessor
Enrolment
124 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01783327
Sponsor's protocol ID
1112009416
Acronym
TeensConnect
Status last verified
Jan 2016
First submitted
28 Jan 2013
Last updated
8 Jan 2016
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Teens-Connect and Planet D in people with Diabetes Mellitus, Type 1, run by Yale University at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Jan 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from baseline hemoglobin A1c over 12 months (time frame: Baseline, 6 weeks, 6 months, 12 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jan 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in